Yi Sun-sin refused the suggestion, saying that people could easily assume there was some kind of favor or privilege being asked for or offered, and he wanted none of that kind of suspicion about him.

In trading on Tuesday, shares of Tarsus Pharmaceuticals Inc (Symbol: TARS) entered into oversold territory, hitting an RSI reading of 29.6, after changing hands as low as $39.25 per share.

Sun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi.

MORRISTOWN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTC:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for ...

Welcome to this week's Chutes & Ladders, our roundup | Incyte’s Hervé Hoppenot is hanging up his hat after spending more than a decade building the company into the multibillion-dollar ...

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection ...

Sun Pharma appoints Kirti Ganorkar as Managing Director, signaling succession planning and change in leadership.

These forward-looking statements are based on Hepion Pharmaceuticals' current expectations and actual results could differ materially.

Hepion Pharmaceuticals appoints Dr. Kaouthar Lbiati as Interim Chief Executive Officer, highlighting leadership changes within the company.

Sun Pharmaceutical Industries Limited has announced appointment of Kirti Ganorkar as the Managing Director to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all ...

Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and NJ HQ expansion.

CNS Pharmaceuticals (NASDAQ: CNSP) announced the release of a Virtual Investor KOL Connect segment featuring Dr. Erin Dunbar, Director of Neuro-Oncol ...